LEADER 01839oam  2200541   450 
001 9910709716903321
005 20181206113247.0
035   $a(CKB)5470000002473081
035   $a(OCoLC)1043948909
035   $a(EXLCZ)995470000002473081
100   $a20180713d2018      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aExamining the drug supply chain $ehearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, December 13, 2017
210  1$aWashington :$cU.S. Government Publishing Office,$d2018.
215   $a1 online resource (vi, 320 pages) $cillustrations
300   $a"Serial No. 115-88."
320   $aIncludes bibliographical references.
517   $aExamining the drug supply chain 
606   $aDrugs$xPrescribing$zUnited States
606   $aPrescription pricing$zUnited States
606   $aMedicine$xResearch$zUnited States
606   $aGeneric drugs$xDevelopment$zUnited States
606   $aCompetition$zUnited States
606   $aConsumer protection$zUnited States
606   $aHealth services accessibility$zUnited States
608   $aLegislative hearings.$2lcgft
615  0$aDrugs$xPrescribing
615  0$aPrescription pricing
615  0$aMedicine$xResearch
615  0$aGeneric drugs$xDevelopment
615  0$aCompetition
615  0$aConsumer protection
615  0$aHealth services accessibility
801  0$bGPO
801  1$bGPO
801  2$bGPO
801  2$bMERUC
801  2$bGPO
801  2$bOCLCF
801  2$bGPO
906   $aBOOK
912   $a9910709716903321
996   $aExamining the drug supply chain$93447192
997   $aUNINA